JP2015503583A5 - - Google Patents

Download PDF

Info

Publication number
JP2015503583A5
JP2015503583A5 JP2014551234A JP2014551234A JP2015503583A5 JP 2015503583 A5 JP2015503583 A5 JP 2015503583A5 JP 2014551234 A JP2014551234 A JP 2014551234A JP 2014551234 A JP2014551234 A JP 2014551234A JP 2015503583 A5 JP2015503583 A5 JP 2015503583A5
Authority
JP
Japan
Prior art keywords
pharmaceutical composition
use according
formulated
component
release
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP2014551234A
Other languages
English (en)
Japanese (ja)
Other versions
JP2015503583A (ja
Filing date
Publication date
Priority claimed from US13/343,332 external-priority patent/US20120135050A1/en
Priority claimed from US13/424,000 external-priority patent/US8236857B2/en
Priority claimed from US13/487,348 external-priority patent/US20120244221A1/en
Application filed filed Critical
Priority claimed from PCT/US2012/051888 external-priority patent/WO2013103390A1/en
Publication of JP2015503583A publication Critical patent/JP2015503583A/ja
Publication of JP2015503583A5 publication Critical patent/JP2015503583A5/ja
Pending legal-status Critical Current

Links

JP2014551234A 2012-01-04 2012-08-22 排尿頻度を減少させるための延長放出製剤およびその使用の方法 Pending JP2015503583A (ja)

Applications Claiming Priority (7)

Application Number Priority Date Filing Date Title
US13/343,332 2012-01-04
US13/343,332 US20120135050A1 (en) 2010-07-08 2012-01-04 Extended-release formulation for reducing the frequency of urination and method of use thereof
US13/424,000 2012-03-19
US13/424,000 US8236857B2 (en) 2010-07-08 2012-03-19 Extended-release formulation for reducing the frequency of urination and method of use thereof
US13/487,348 2012-06-04
US13/487,348 US20120244221A1 (en) 2010-07-08 2012-06-04 Extended-release formulation for reducing the frequency of urination and method of use thereof
PCT/US2012/051888 WO2013103390A1 (en) 2012-01-04 2012-08-22 Extended-release formulation for reducing the frequency of urination and method of use thereof

Related Child Applications (1)

Application Number Title Priority Date Filing Date
JP2016178118A Division JP2017031172A (ja) 2012-01-04 2016-09-13 排尿頻度を減少させるための延長放出製剤およびその使用の方法

Publications (2)

Publication Number Publication Date
JP2015503583A JP2015503583A (ja) 2015-02-02
JP2015503583A5 true JP2015503583A5 (enExample) 2015-08-27

Family

ID=48745355

Family Applications (4)

Application Number Title Priority Date Filing Date
JP2014551234A Pending JP2015503583A (ja) 2012-01-04 2012-08-22 排尿頻度を減少させるための延長放出製剤およびその使用の方法
JP2016178118A Pending JP2017031172A (ja) 2012-01-04 2016-09-13 排尿頻度を減少させるための延長放出製剤およびその使用の方法
JP2018016869A Pending JP2018087217A (ja) 2012-01-04 2018-02-02 排尿頻度を減少させるための延長放出製剤およびその使用の方法
JP2019203550A Pending JP2020037575A (ja) 2012-01-04 2019-11-08 排尿頻度を減少させるための延長放出製剤およびその使用の方法

Family Applications After (3)

Application Number Title Priority Date Filing Date
JP2016178118A Pending JP2017031172A (ja) 2012-01-04 2016-09-13 排尿頻度を減少させるための延長放出製剤およびその使用の方法
JP2018016869A Pending JP2018087217A (ja) 2012-01-04 2018-02-02 排尿頻度を減少させるための延長放出製剤およびその使用の方法
JP2019203550A Pending JP2020037575A (ja) 2012-01-04 2019-11-08 排尿頻度を減少させるための延長放出製剤およびその使用の方法

Country Status (13)

Country Link
US (3) US8685453B2 (enExample)
JP (4) JP2015503583A (enExample)
KR (2) KR20140108675A (enExample)
AU (2) AU2012363789B2 (enExample)
BR (1) BR112014016661A8 (enExample)
CA (1) CA2856677A1 (enExample)
IL (1) IL232715A0 (enExample)
MX (1) MX2014008283A (enExample)
MY (1) MY173582A (enExample)
RU (1) RU2603471C2 (enExample)
SG (1) SG11201500407XA (enExample)
WO (1) WO2013103390A1 (enExample)
ZA (1) ZA201404606B (enExample)

Families Citing this family (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US9532959B2 (en) 2010-07-08 2017-01-03 Wellesley Pharmaceuticals, Llc Pharmaceutical formulation for reducing frequency of urination and method of use thereof
CA2842072A1 (en) 2011-07-18 2013-01-24 James V. Snider Methods of treating cardiovascular diseases and predicting the efficacy of exercise therapy
KR102045592B1 (ko) * 2012-03-30 2019-11-15 지보당 에스아 식품 향미 화합물로서의 n-아실 프롤린 유도체
AU2014396189A1 (en) * 2014-06-06 2016-12-22 Wellesley Pharmaceuticals, Llc Pharmaceutical formulation for reducing frequency of urination and method of use thereof
AU2014407186A1 (en) * 2014-09-24 2017-03-09 Wellesley Pharmaceuticals, Llc Pharmaceutical formulation for reducing bladder spasms and method of use thereof
EP3344240A4 (en) * 2015-09-01 2019-09-04 Wellesley Pharmaceuticals, LLC FORMULATION WITH EXTENDED, DELAYED AND IMMEDIATE RELEASE, METHOD FOR THE PRODUCTION AND USE THEREOF
MX2018002449A (es) * 2015-09-01 2018-08-24 Wellesley Pharmaceuticals Llc Formulaciones de liberacion retardada, metodos de fabricacion y uso de las mismas.
WO2017058436A1 (en) * 2015-09-30 2017-04-06 Wellesley Pharmaceuticals, Llc Composition for reducing the frequency of urination, method of making and use thereof
TW201726114A (zh) * 2015-11-23 2017-08-01 魏斯理製藥公司 降低排尿頻率之組成物、其製備方法、及其應用
JP7229012B2 (ja) * 2018-12-25 2023-02-27 小林製薬株式会社 内服用医薬組成物
JP2019069991A (ja) * 2018-12-27 2019-05-09 ウェルズリー ファーマスーティカルズ、エルエルシー 膀胱痙攣を低減するための医薬製剤およびその使用の方法

Family Cites Families (31)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
HU219332B (hu) * 1991-09-06 2001-03-28 Mcneilab Inc Transz-(+)-2-[(dimetil-amino)-metil]-1-(3-metoxi-fenil)-ciklohexanolt és acetaminofent tartalmazó szinergetikus gyógyszerkészítmények
JP4085433B2 (ja) * 1997-04-11 2008-05-14 日本新薬株式会社 頻尿・尿失禁治療剤
US7138393B2 (en) * 1998-07-24 2006-11-21 Wyeth Biologically active vasopressin agonist metabolites
JP3660979B2 (ja) * 2000-09-05 2005-06-15 国立大学法人金沢大学 夜間頻尿症の治療剤、夜間頻尿症の予防剤
RU2193401C1 (ru) * 2001-04-02 2002-11-27 Аль-Шукри Салман Хасунович Способ лечения гиперактивности мочевого пузыря
WO2003043655A1 (fr) * 2001-11-19 2003-05-30 Ono Pharmaceutical Co., Ltd. Remedes pour la frequence urinaire
KR20050005410A (ko) * 2002-02-19 2005-01-13 파마시아 코포레이션 요실금 치료용으로서의 시클로옥시게나제 저해제 및항무스카린제의 용도
WO2004007495A1 (ja) * 2002-07-11 2004-01-22 Takeda Pharmaceutical Company Limited ピロロピリジン誘導体およびその用途
KR100522239B1 (ko) * 2002-07-16 2005-10-18 주식회사 서울제약 아세트아미노펜을 함유하는 제어방출성의 경구용 제제
US20050152905A1 (en) * 2002-08-22 2005-07-14 Omoigui Osemwota S. Method of biochemical treatment of persistent pain
US20040054008A1 (en) * 2002-09-13 2004-03-18 Tohru Araki Medicament for treatment of nocturia
ATE386509T1 (de) * 2002-09-21 2008-03-15 Shuyi Zhang Formulierung von acetaminophen und tramadol mit verzögerter freisetzung
US20040186180A1 (en) * 2003-03-21 2004-09-23 Gelotte Cathy K. Non-steroidal anti-inflammatory drug dosing regimen
EP1492519B1 (en) * 2003-03-21 2006-11-15 Dynogen Pharmaceuticals, Inc. Methods for treating lower urinary tract disorders using antimuscarinics and alpha-2-delta subunit calcium channel modulators
US8029822B2 (en) 2003-05-22 2011-10-04 Osmotica Kereskedelmi és Seolgáltató KFT Rupturing controlled release device having a preformed passageway
US20040248979A1 (en) * 2003-06-03 2004-12-09 Dynogen Pharmaceuticals, Inc. Method of treating lower urinary tract disorders
DE10356112A1 (de) 2003-11-27 2005-06-23 Boehringer Ingelheim Pharma Gmbh & Co. Kg Pharmazeutische Zusammensetzung aus einem Beta-3-Adrenozeptor-Agonisten und einem in den Prostglandinstoffwechsel eingreifendem Wirkstoff
EP1627876A1 (en) * 2004-08-20 2006-02-22 Ferring B.V. Heterocyclic condensed compounds useful as antidiuretic agents
WO2006059237A1 (en) * 2004-08-30 2006-06-08 Lunamed, Inc. 4-phenylbutyric acid controlled-release formulations for therapeutic use
EP1879578A4 (en) * 2005-03-21 2009-05-13 Dov Pharmaceutical Inc METHODS AND COMPOSITIONS FOR THE TREATMENT OF URINARY INCONTINENCE
EP1871372A4 (en) * 2005-04-08 2010-06-02 Neuromed Pharmaceuticals Ltd COMBINATION THERAPY WHICH INCLUDES AN AGENT BLOCKING CALCIUM CHANNELS OF TYPE N FOR THE RELIEF OF PAIN
MX2008000967A (es) * 2005-07-20 2008-03-26 Panacea Biotec Ltd Nueva composicion farmaceutica de forma de dosis de liberacion modificada que comprende inhibidor de enzima ciclooxigenasa.
US20080085314A1 (en) * 2005-07-29 2008-04-10 Shalaby Shalaby W Solid oral formulations for combination therapy
US20080166407A1 (en) 2005-07-29 2008-07-10 Shalaby Shalaby W Solid oral formulations for combination therapy
WO2007072503A2 (en) * 2005-12-21 2007-06-28 Panacea Biotec Ltd. Combinations for managing inflammation and associated disorders
US20070237816A1 (en) * 2006-04-06 2007-10-11 David Finkelstein Acetaminophen formulation for joint pain relief
WO2008014175A2 (en) 2006-07-28 2008-01-31 Dr. Reddy's Laboratories Ltd. Granular pharmaceutical compositions
US20080057122A1 (en) * 2006-08-31 2008-03-06 Aaipharma Inc. Acetaminophen pharmaceutical compositions
PL2190418T3 (pl) * 2007-08-15 2014-03-31 Mcneil Ppc Inc Sposób dawkowania ibuprofenu o natychmiastowym i długotrwałym uwalnianiu
GB201003731D0 (en) * 2010-03-05 2010-04-21 Univ Strathclyde Immediate/delayed drug delivery
JP2018016869A (ja) * 2016-07-29 2018-02-01 日立化成株式会社 アルミニウム系多孔質体及びその製造方法

Similar Documents

Publication Publication Date Title
JP2015506359A5 (enExample)
RU2014131238A (ru) Состав с отсроченным высвобождением для уменьшения частоты мочеиспускания и способ его применения
JP2015510928A5 (enExample)
MX2015011896A (es) Formulacion de liberacion sostenida de mosapride que proporciona efectos farmacologicos y clinicos con administracion una vez al dia.
JP2013517304A5 (enExample)
JP2016528302A5 (enExample)
JP2015038135A5 (enExample)
RU2017137643A (ru) Составы l-орнитин фенилацетата
HRP20171743T1 (hr) Sastavi i postupci za savladavanje otpornosti na tramadol
JP2012505884A5 (enExample)
RU2016133305A (ru) Состав с длительным высвобождением для снижения частоты мочеиспускания и способ его применения
RU2603471C2 (ru) Состав с замедленным высвобождением для снижения частоты мочеиспускания и способ его применения
HRP20161340T1 (hr) Formulacije darunavira
AR052225A1 (es) Formulaciones de tabletas de liberacion modificada par inhibidores de la bomba de protones
HRP20240045T1 (hr) Tablete s trenutnim oslobađanjem koje sadrže lijek i postupci za proizvodnju tableta
JP2013516493A5 (enExample)
JP2012082195A5 (enExample)
JP2015522659A5 (enExample)
JP2015522658A5 (enExample)
JP2007509965A5 (enExample)
CA2778825C (en) Treatment of sunburn using analgesics and antihistamines
TWI629059B (zh) 解熱鎮痛組成物
RU2016152226A (ru) Фармацевтический состав для уменьшения частоты мочеиспускания и способ его применения
JP2018526414A5 (enExample)
JP2006517557A5 (enExample)